Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol in traumatic brain injury ICU patients
IRCT20200824048500N1Phase 2Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of dexmedetomidine and propofol in traumatic brain injury (TBI) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Neuron-specific enolase and S100 calcium-binding protein B. Started Feb 2021; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20200824048500N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200824048500N1.